The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China.
about
Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature reviewFunctional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala LumpurThe problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin AmericaPrimary Antibiotic Resistance of Helicobacter pylori in China.Treatment of Helicobacter pylori infection: current status and future concepts.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Gastric Juice-Based Real-Time PCR for Tailored Helicobacter Pylori Treatment: A Practical Approach.Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?Centralized isolation of Helicobacter pylori from multiple centers and transport condition influences.Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivoThe Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Effect of bacterial and host factors on Helicobacter pylori eradication therapyFrequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran.Efficacy and safety of high dose dual therapy for Helicobacter pylori rescue therapy: A systematic review and meta-analysis.Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infectionThe Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.Validation of a High-Throughput Multiplex Genetic Detection System for Helicobacter pylori Identification, Quantification, Virulence, and Resistance Analysis.Review article: the global emergence of Helicobacter pylori antibiotic resistance.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from ChinaEffect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.Guidelines for treatment of Helicobacter pylori in the East and West.Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.Review: clinical management of Helicobacter pylori infection in China.Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection.Role of bismuth in improving Helicobacter pylori eradication with triple therapy.A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis.Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori.Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study.Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years.Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15-Year Study.In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria.
P2860
Q26785651-FE129851-78DD-487F-8B45-9E77F394E7A8Q28540466-6502B6B8-9CE0-4B08-A75D-691B1162BE3DQ30217199-F280F243-8F62-4E03-B11B-2E93A1BF980CQ30235219-BE8E82B8-32A3-41CC-BB06-9773EF18A0B9Q33594850-23A9AC51-F6B0-4257-89EA-ECCDFF6BADFAQ33639114-73DBE0CE-452E-4353-AAB4-A71EED1A9644Q33820650-C0498789-DA28-4C0C-9C58-79EB75D9A4C2Q34255425-DCDD3C0B-3587-4211-A8EA-431AB5D22B7DQ34983201-04D1E61A-9BB4-479E-AE8F-57C7DDCAF987Q34986052-78435373-F194-4036-BEA5-1517749F2F40Q35375400-9A605ED7-68CA-421F-9D57-920960A8C48FQ35571249-695587D6-0AF5-4005-B681-821D2EA94544Q35598058-9BCC6174-B053-4558-BA9A-4B9CD6FD2BD7Q35738262-2654FDBB-AFBC-4CC5-9557-68C443DB9816Q35744435-50368DC8-F716-4274-BB68-7A85D53E6BCEQ36224538-BBDA1482-C6D5-41C8-BB8B-2DA4A0A022A4Q36360817-588A60C3-EA18-439C-9F31-D74564931190Q36410419-A7C62CCB-6FDF-4480-B811-9F58ACFEC886Q36653595-6CEE996F-E3A7-49F3-8F51-5EA574FB2A14Q37026545-F532DDF3-BF6A-4837-89F4-C0D6318024CDQ37235639-8D49638A-F724-486B-B776-787EEE08D5ECQ37340339-2A33196D-6DCE-42B4-921F-5C1EDB9D5EF9Q37378899-9EE9D4CD-E838-4502-B614-09922AD5DA12Q37397744-BFB112CF-D168-42D2-999E-56622B792069Q37682593-422889B9-3004-444B-B2E6-91551687A791Q37912220-B0213449-7174-4015-8A1E-974F30CEB695Q38029324-3FF95D6C-3652-4467-BA89-3975159B7ADEQ38238745-66328E39-5E58-489C-86DF-DD6292DC5877Q38238746-998C8E12-35A9-43E1-9BB5-FE910BD240BCQ38266432-C1CFB38D-14BC-4E0D-871B-EBAEA350BDEEQ38621376-7B93E9E0-D954-45D0-94D0-3330DD4E861BQ38723877-3C43658D-FD10-4A4E-A41C-EBCDF70DA9CFQ38888977-EC442A7C-418F-46E6-9D12-AB9EEB54F55AQ40101139-F9B9F68D-A4B8-4F07-A482-31E65125F120Q40206483-0F48A50D-9BEC-46A0-AA7D-A38BB1FA0CC8Q40367710-3509F711-70EB-45D6-8692-D5EF3C537D91Q40608192-F4EF5F8D-1F04-4EA9-AD53-3540CA441C7BQ40831117-8BC96F19-4C02-4E38-B187-F1436E8C6CE4Q40915777-A1486502-F68B-4025-AB96-8D06DB506682Q40953699-7A33FB91-0C9C-4A13-B818-5755856BB944
P2860
The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The evolution of Helicobacter ...... er 10 years in Beijing, China.
@en
The evolution of Helicobacter ...... er 10 years in Beijing, China.
@nl
type
label
The evolution of Helicobacter ...... er 10 years in Beijing, China.
@en
The evolution of Helicobacter ...... er 10 years in Beijing, China.
@nl
prefLabel
The evolution of Helicobacter ...... er 10 years in Beijing, China.
@en
The evolution of Helicobacter ...... er 10 years in Beijing, China.
@nl
P2093
P2860
P1433
P1476
The evolution of Helicobacter ...... er 10 years in Beijing, China.
@en
P2093
Guibin Yang
Hong Cheng
Lihui Wang
Xiaoli Zheng
P2860
P304
P356
10.1111/J.1523-5378.2010.00788.X
P577
2010-10-01T00:00:00Z